United States Home Infusion Therapy Market revenue worth $16.5 Bn by 2026

U.S. Home Infusion Therapy Market size is set to cross USD 16.5 billion by 2026; according to a new research report by Global Market Insights Inc.
 

Growing geriatric population susceptible to various chronic disorders is one of the foremost factors enhancing the growth of U.S. home infusion therapy market. Increase in number of nosocomial infections are enabling patients to shift towards home healthcare facilities thereby, spurring the market growth. Requirement of home infusion therapy for several medical conditions including dehydration, vomiting and other serious diseases such as Crohn's disease will further propel the market growth. Also, technological advancements related to infusion therapy will significantly contribute to the market growth thereby, supporting the industry expansion.  
 

Increasing prevalence of various chronic disorders across elderly population will boost the market growth in the future

Increasing number of nosocomial infections in hospitals and other healthcare facilities have triggered the need for alternative long term treatment. Presence of home healthcare facilities including home care aid organizations and home healthcare agencies as an alternative to clinics and hospitals have propelled the market growth dramatically. Factors such as better monitoring, cost-effective treatment, higher patient convenience, among others have attracted considerable number of patients, thereby boosting the market growth positively.
 

The home infusion therapy can be used for the treatment of chronic diseases such as asthma, rheumatoid arthritis, gastrointestinal diseases and many more. Growing elderly population and changes in societal behavior are contributing to a steady increase in these chronic diseases and medical conditions thereby, enhancing the demand for home infusion therapy. For instance, according to a recently published data by the Centers for Disease Control and Prevention (CDC), more than 25 million Americans are currently living with asthma. Thus, owing to such large population suffering from asthma, home infusion therapy market will witness substantial growth over the analysis timeframe.
 

Browse key industry insights spread across 250 pages with 292 market data tables & 15 figures & charts from the report, “U.S. Home Infusion Therapy Market Size By Product (Infusion Pumps, Intravenous Sets, IV Cannulas, Needleless Connectors), By Application (Anti-infective, Hydration Therapy, Chemotherapy, Enteral Nutrition, Parenteral Nutrition, Specialty Pharmaceuticals), Industry Analysis Report, Zonal Outlook, Growth Potential, Price Trends, Competitive Market Share & Forecast, 2020 – 2026” in detail along with the table of contents:
https://www.gminsights.com/industry-analysis/us-home-infusion-therapy-market
 

Rising adoption of advanced treatment options coupled with availability of skilled medical professionals in the U.S. will enhance the segmental growth

The intravenous sets segment was valued at around USD 1.1 billion in 2019 and is expected to showcase substantial growth over the forecast period. The segmental growth is attributed to the factors such as increasing incidence of chronic diseases and rise in the adoption of advanced treatment options for infusion therapy. The intravenous treatments that can be received at home include treatment for hormone deficiencies, medicines for severe nausea and patient-controlled analgesia.
 

In addition, a rising number of surgeries will foresee an increase in number of intravenous sets. According to the company Natura, about 75% of the Americans remain dehydrated that can lead to chronic to acute problems. Hence, these disorders will stimulate the adoption of intravenous infusion therapy in U.S. Furthermore, owing to the availability of skilled and licensed healthcare professionals to administer intravenous infusions in a sterile process at home, the demand for home infusion therapy will increase in the upcoming years.
 

Large patient pool suffering from antibiotic resistant infections will positively impact the segmental growth

The anti-infective application segment held around 27% of the U.S. home infusion therapy market in 2019. Increasing prevalence of infectious diseases and antimicrobial resistance to existing anti-infective agents are the factors that will propel the segmental growth thereby, spurring the market growth. For instance, according to a recently published data by the Centers for Disease Control and Prevention (CDC), every year more than 2.8 million people in the U.S. receive an antibiotic resistant infection. Thus, this will in turn trigger the need for anti-infective medications thereby, enhancing the market growth.
 

Easy availability of patient care organizations and home health agencies across the country will augment the market growth

South Atlantic home infusion therapy market held around 20% share in 2019 and is expected to grow at significant growth rate over 2020 to 2026. The growth is owing to the presence of pharmacy based patient care organizations across the zone, that will boost the overall U.S. market growth in the upcoming years. For instance, Amerita South Atlantic LLC is one of the home infusion therapy pharmacies that provides care to the patients with acute and chronic conditions. It provides the services such as parenteral administration of drugs, biologics and nutritional procedures administered through catheters and needles at home. Also, increasing prevalence of diseases requiring infusion therapies will boost the demand for home infusion therapy.
 

West North Central home infusion therapy market was valued at USD 593.7 million in 2019 and is anticipated to showcase lucrative growth in the projected years. Availability and accessibility to home health agencies and specialized infusion companies across the country will augment the zonal growth thereby, spurring the overall market growth positively. Increasing number of caregivers that assist in administering the medication to patients at home will fuel the market growth in the coming years. In order to properly administer, store and dispose the medications at home, the pharmacists in the U.S. are focusing on training the caregivers such as family members.
 

Companies focusing on new product launches and strategic acquisitions will contribute to the market growth

Some of the prominent players in U.S. home infusion therapy market share are Amsino International, Baxter International, Becton Dickinson, Halyard Health, ICU Medical, Moog and Smiths Medical among others. These market players are majorly focusing on various strategies such as collaborations, new product launches, acquisitions and partnerships. For instance, in February 2017, ICU Medical completed the acquisition of the Hospira Infusion Systems (HIS) business from Pfizer Inc. This strategic move expanded the company’s product portfolio thereby, supporting the industry growth.